Abstract
BMP signaling deficiency is evident in the lungs of patients with pulmonary arterial hypertension. We demonstrated that PHD2 deficiency suppresses BMP signaling in the lung endothelial cells, suggesting the novel mechanisms of dysregulated BMP signaling in the development of pulmonary arterial hypertension.
Original language | English (US) |
---|---|
Article number | e12056 |
Journal | Pulmonary Circulation |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2022 |
Funding
This study was supported in part by NIH grants R01HL140409, R01HL133951, R01HL148810 to You‐Yang Zhao, and NIH R00HL13827, AHA Career Development Award 20CDA35310084, ATS Foundation Pulmonary Hypertension Association Research Fellowship, Arizona Biomedical Research Centre funding (ADHS18‐198871), and the University of Arizona departmental Startup funding to Zhiyu Dai. The authors thank the Pulmonary Hypertension Breakthrough Initiative for providing the lung endothelial cells from IPAH patients and failed donors. Funding for the Pulmonary Hypertension Breakthrough Initiative is provided under an NHLBI R24 grant (R24HL123767).
Keywords
- BMPR2
- angiogenesis
- hypoxia
- pulmonary hypertension
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine